Abstract:
The field of biomedical research and therapeutic innovation is changing as a result of the convergence of molecular biology, nanotechnology, and nanomedicine. The fundamental knowledge of genetic and cellular systems provided by molecular biology acts as a guide for the logical creation of instruments at the nanoscale. Nanotechnology provides previously unheard-of control over the atomic and molecular level of material design, allowing for the development of precisely tailored nanoparticles, biosensors, and delivery systems. Nanomedicine, the clinical application of nanotechnology in healthcare, harnesses these innovations to enhance diagnostics, targeted drug delivery, and personalized therapies. Innovations like CRISPR-Cas9 delivery vehicles for gene editing, smart nanocarriers that react to cellular surroundings, and nanoscale diagnostic systems that can identify diseases in their early stages are being fuelled by this interdisciplinary synergy. In addition to advancing our knowledge of biological systems, bridging these domains speeds up the creation of cutting-edge medical technologies that promise safer, more efficient, and highly customised therapies for a variety of illnesses.

Keywords: Molecular biology, Nanotechnology, Nanomedicine, Interdisciplinary research, Targeted drug delivery.